Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

DiaMedica Therapeutics Inc. Common Stock (DMAC)

Pharmaceutical Preparations

https://www.diamedica.com

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS, MN

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

11/29/2007

Market Cap

150,899,734

Shares Outstanding

37,950,000

Weighted SO

37,953,711

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

MIST --.--%

MCRB --.--%

IKT --.--%

ONCY --.--%

SCPH --.--%

LIFE --.--%

LYRA --.--%

CNTA --.--%

IOVA --.--%

Beta

1.4910

Last Div

0.0000

Range

1.9382-3.8056

Chg

0.0200

Avg Vol

60661

Mkt Cap

150899734

Exch

NASDAQ

Country

US

Phone

763 612 6755

DCF Diff

3.4028

DCF

0.1272

Div Yield

0.0000

P/S

4.8933

EV Multiple

-5.0936

P/FV

2.5158

Div Yield %

0.0000

P/E

-6.7522

PEG

0.4389

Payout

0.0000

Current Ratio

17.8154

Quick Ratio

17.8154

Cash Ratio

4.5551

DSO

4.6279

DIO

0.0000

Op Cycle

4.6279

DPO

53.4507

CCC

-48.8228

Gross Margin

0.8319

Op Margin

-0.8742

Pretax Margin

-0.6440

Net Margin

-0.6454

Eff Tax Rate

-0.0008

ROA

-0.3504

ROE

-0.3856

ROCE

-0.5020

NI/EBT

1.0022

EBT/EBIT

0.7367

EBIT/Rev

-0.8742

Debt Ratio

0.0068

D/E

0.0073

LT Debt/Cap

0.0054

Total Debt/Cap

0.0072

Int Coverage

-4.6778

CF/Debt

-50.1797

Equity Multi

1.0632

Rec Turnover

78.8696

Pay Turnover

6.8287

Inv Turnover

0.0000

FA Turnover

65.7527

Asset Turnover

0.5430

OCF/Share

-0.5114

FCF/Share

-0.5120

Cash/Share

1.4199

OCF/Sales

-0.6314

FCF/OCF

1.0011

CF Coverage

-50.1797

ST Coverage

-194.6973

CapEx Coverage

-900.0926

Div&CapEx Cov

-900.0926

P/BV

2.5158

P/B

2.5158

P/S

4.8933

P/E

-6.7522

P/FCF

-7.7419

P/OCF

-6.9021

P/CF

-6.9021

PEG

0.4389

P/S

4.8933

EV Multiple

-5.0936

P/FV

2.5158

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation